In the News

Prefillled Syringes Show Strong Growth

Innovation: Moving the Needle

ApiJect’s Strategy and Adaptation of BFS Technology

ApiJect Top 10 Drug Delivery Solutions Provider

PFS & Parenteral Drug Delivery: Self-Injection is Very Much the “New Normal”

“Why Don’t I Try?”

ASPR Celebrates Construction of New R&D Facility for Production of Prefilled Injectors

How Lessons from Ebola can Help in the Fight Against COVID-19

Op-Ed: A lesson from Ebola in 2015 will be key to ending COVID-19

Injection Devices: Designing Simplicity, Safety & Adherence Into One Delivery System

Syringe Supplies Among Major Challenges Facing Global Coronavirus Vaccine Rollout

A Looming Challenge In The Vaccination Campaign: Syringe Shortages

Ed Kelley and Global Health Leaders Highlight Injection Safety

Opinion: The global vaccine effort will be a hollow victory if it leads to unsafe injection practices

4 Innovations that Found their Use Case During the Pandemic

How a single dose syringe can revolutionize vaccination campaigns

The Apiject Gigafactory, Featuring the World’s Largest Pharmaceutical Fill-Finish Facility

In COVID-19 fight, ApiJect is Ready To Produce 45 Million Prefilled Syringes A Month

Gigafactory’ Campus that will be Used for Vaccine Production Coming to RTP

Stamford Company may Play Critical Role in COVID Vaccine Delivery

U.S. Government Announces Approval of $590M Loan to Build Domestic Fill-Finish Facility

ApiJect included in Operation Warp Speed update announcement from HHS

Labels on ApiJect BFS PFS to be Manufactured at RAPID Facilities could include Dose-Serialized NFC Tags

How ApiJect is working with the U.S. Government on COVID-19 Response

DoD-HHS Announce $138M to Accelerate BFS Prefilled Syringes

White House Ramps Up U.S. Surge Capacity to Package COVID-19 Drugs and Vaccines

Will RAPID Partnership Save the Day in Vaccination Supplies?

U.S. Creating Prefilled Syringes for Coronavirus Fight

Jefferies to Lead Urgent Initiative to Raise Capital for The RAPID Consortium

RAPID Consortium Chairman Says it is Time the U.S. Goes on the Offense Against COVID-19

HHS Announces New Public-Private Partnership to Develop US-Based, High-Speed Emergency Drug Packaging Solutions

How this Private Company is Working on Vaccine Delivery